Novartis Investigative Site

Munich 80638

0 studies enrolling now · 7 studies all time

What they study most

Acute Gout, Atherosclerotic Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Familial Hypercholesterolemia, Heart Failure With Preserved Ejection Fraction, Leukemia, Myeloid, Chronic, Migraine, Symptomatic Atherosclerosis, Type2 Diabetes

Studies at this site

• An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol — Completed
• A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients — Completed
• Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase — Stopped early
• Efficacy and Safety of BGG492 in the Treatment of Migraine — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients — Completed